Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Controlled Trial on the Efficacy and Safety of Rimegepant in the Treatment of Acute Dizziness

NCT07435090 is registered in ClinicalTrials.gov with Shi Tianming as lead sponsor.

NCT NCT07435090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07435090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Controlled Trial on the Efficacy and Safety of Rimegepant in the Treatment of Acute Dizziness
Lead sponsor
Shi Tianming
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
March 20, 2026
Completion date
June 30, 2028
Enrollment
370 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dizziness